Kenvue is the name of one of Johnson & Johnson’s planned two new, independent, maket leading companies. Two powerful ideas inspire the name: ‘ken’ – meaning knowledge, an English word primarily used in Scotland, and ‘vue,’ referencing sight. With rich knowledge of human needs and deep consumer insights, Kenvue will deliver meaningful, personal health solutions.
“Unveiling the Kenvue brand is a defining moment for our stakeholders and an important part of the planned separation. We breathe life into some of the world’s most iconic and beloved brands every day, so we harnessed that same expertise, love, and energy into developing our new corporate identity,” said Thibaut Mongon, CEO Designate, Kenvue.
Kenvue’s purpose, Realize the Extraordinary Power of Everyday Care, will guide the company’s actions and long-term aspirations, from strategy to talent philosophy, and more. The company's visual identity represents timelessness while allowing space for iconic brands also to have a home.
“Today’s announcement is another milestone for the Consumer Health business. Kenvue is poised to thrive as a standalone company with a leading portfolio of brands consumers love and trust. I’m confident in this team and excited to see what the future holds,” said Joaquin Duato, Chief Executive Officer of Johnson & Johnson.
Kenvue’s iconic portfolio of brands will include Aveeno, Band-Aid, Listerine, Neutrogena, Tylenol and Johnson’s.
